#MedicalTechnology software forms an important part of the #medicaldevice industry and recent changes to the #regulatory landscape across regions is bound to affect the medical technology industry. This whitepaper compares FDA and EU approaches https://t.co/fWSyzo0E7G
Hear first-hand from a scientist working on spinal cord regeneration therapy. He has identified a receptor molecule on the axons called protein tyrosine phosphatase sigma (PTPσ) that acts to help CSPGs adhere axons to spinal cord tissue https://t.co/UZeHq9tvXJ
72% of #microbiome therapeutics professionals say that it is critical to invest in #technology at the pre-clinical stage or earlier. We take a deep dive into the data around emerging technologies from our recent survey https://t.co/YkhgFGQNJQ
#TIDESTV talks to Dr Jo-Anne Riley @Intertek about how the company is approaching key challenges in #oligonucleotide characterization and analysis. https://t.co/Co9WXfyMMB
The futuristic end-concept of expansive virtual clinical trials is an exciting one and steps toward this end are beginning to appear. However, with true virtual trials still in their infancy, just how close are we to widescale implementation? https://t.co/OQfbMgF2wy
What are the obstacles in integrating #AI into #clinicaltrials and how can (and should) they be solved? We put the question to seven industry experts. https://t.co/ktZOLPQIHG
Over the last two decades, a phenomenal evolution of bispecific antibodies has developed. Get the run down of all the bispecific antibody clinical trials – both oncological and non-oncological – currently running https://t.co/vfxoacRdtH
Peptide cancer and infectious disease vaccines have an exciting potential future. This whitepaper looks at synthetic peptide and personalized cancer vaccines and the companies currently developing them https://t.co/a84hNILHlK
Join us at #biotechweekboston at booth 224 to find out more about our partnership with @BioProcessIntl. BioProcess International Academy's vision is to accelerate the growth of the biopharmaceutical sector by providing training solutions that drive the industry forward.
Artificial intelligence is beginning to have an important impact on human health. We profile seven women who are using #AI to solve some of healthcare’s biggest problems https://t.co/rmjMvnQBHw
Human microbiome therapeutics is one of the most exciting emerging fields around, but there are still huge regulatory hurdles that need to be overcome to achieve commercial success. We spoke to eight industry experts about how to do this https://t.co/BebOJduqcF
Calling all professionals in #antibody engineering and therapeutics! Does your project use emerging technologies such as #AI and next generation sequencing? Complete our survey for the chance to win a free conference pass ->
https://t.co/pzl22FnbEl
Join us for a free webinar -guided by Trefor Jones, course leader for A Practical Guide to Single Use Technologies you will gain an overview of the fundamentals of the biotechnology industry. https://t.co/lk4ITVURCA
Join Roger Holdsworth, trainer for day 2 of our Pharma and Biopharm Mini-MBA for a free webinar, A Process for Managing Change: 6 September 2018 at 2 - 2.30pm. Register here: https://t.co/GW2uDcSkgn #pharmaceutical#webinar#strategy